Metabiomics
  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
Select Page
MultiTag Sequencing™ Services Now Available for Genomics Research Applications

MultiTag Sequencing™ Services Now Available for Genomics Research Applications

by Greg Kuehn | Apr 15, 2011 | Press Releases, Research News

Manassas, VA (April 15, 2009) — Metabiomics© is now offering the human Genomics research community advanced MultiTag Sequencing™ primers and services including a limited license to use its patent pending MultiTag Sequencing™ method for research purposes. This...
Metabiomics Awarded Qualifying Therapeutic Discovery Project Grant

Metabiomics Awarded Qualifying Therapeutic Discovery Project Grant

by Greg Kuehn | Nov 5, 2010 | Press Releases, Research News

Biotechnology Grant Award Launches Metabiomics Human Microbiome Commercialization Initiative Potomac Falls, Virginia – November 5, 2010: Metabiomics, a human microbiome biomarker discovery and molecular diagnostics company, announced that that it was awarded a grant...
MultiTag Sequencing™ Patent Application Advances to National Phase

MultiTag Sequencing™ Patent Application Advances to National Phase

by Greg Kuehn | Jun 7, 2010 | Press Releases

Metabiomics© announced that it received a favorable International Preliminary Report on Patentability from the Patent Cooperation Treaty (PCT) on its application to patent its enabling MultiTag Sequencing™ (MTPS) method for unique identification of multiple samples...
Breakthrough MultiTag Sequencing™ Primers and Services Now Available for Metagenomics Research

Breakthrough MultiTag Sequencing™ Primers and Services Now Available for Metagenomics Research

by Greg Kuehn | Jun 7, 2010 | Press Releases, Research News

Advanced MultiTag Sequencing™ primer kits and full line of pyrosequencing services are now available from Metabiomics© to the Microbiome research community to increase throughput, productivity, and comparative statistical analysis, differentiating subject populations,...
New Microbiome Research Center Advances MultiTag Sequencing™ Technology

New Microbiome Research Center Advances MultiTag Sequencing™ Technology

by Greg Kuehn | Apr 15, 2009 | Press Releases, Research News

Manassas, VA (April 15, 2009) – The newly organized MicroBiome Analysis Center (MBAC) at George Mason University has partnered with Metabiomics to map the world that bacteria, viruses, fungi and protozoa inhabit the human body called the Human Microbiome. The MBAC has...
Next Entries »

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening March 20, 2020
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test December 17, 2019
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer September 5, 2019

Tag Cloud

Breakthrough Device China clinical studies colon cancer screening colon cancer test colon polyp Colorado Capital Conference colorectal adenoma colorectal cancer colorectal cancer diagnostics colorectal cancer screening CoreBiome Curtis Huttenhower Dan Knights Harvard Investor conference Keri Donaldson Kindstar LifeKit Prevent MB-01 MBAC Metabiomics Metagenomics Microbiome microbiome diagnostics microbiome sampling kit Mid-Atlantic Bio molecular diagnostics MultiTag Sequencing neoplasia Next-Generation Sequencing OCTANe Medical Device & Investor Forum Oricol Origin Sciences patents Patrick Gillevet Prescient Medicine Series A

RSS Feeds

  • RSS - Posts
  • RSS - Comments

Recent News

  • Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening
  • Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
  • FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer

Navigation

  • Home
  • LifeKit® Prevent
  • Technology
    • Microbiome Health
    • Microbiome Research News
    • Publications
  • About Us
    • Press Releases
    • Management
    • Careers
  • Contact Us
  • Facebook
  • X
  • RSS

Designed by Elegant Themes | Powered by WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}